EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
2012
Purpose:To assess the effects of verteporfin photodynamic therapy (PDT) combined with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.Methods:In this multicenter, double-masked, primarily indocyanine green angiography–guided
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
412
Citations
NaN
KQI